Drugs / Cultivated oral mucosal epithelial cell transplantation
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03943797 | Mar 2016 → Dec 2024 | limbal stem cell deficiency | Chang Gung Memorial Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cultivated oral mucosal epithelial cell transplantation | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03943797 ↗ |
| Known as | COMET | “Cultivated oral mucosal epithelial cell transplantation (COMET) will be used to treat severe limbal stem cell deficiency so as to restore the integrity of corneal surface” NCT03943797 ↗ |
| Modality | Cell therapy | “Cell therapy for treating severe limbal stem cell deficiency using cultivated autologous oral mucosal epithelial cells.” NCT03943797 ↗ |